Study S002779

A Study to Evaluate the Efficacy and Safety of Noiiglutide Injection in Type 2 Diabetes Patients Who Received Metformin in Combination With or Without Another Oral Hypoglycemic Drug for Poor Blood Glucose Control -- a Phase III Clinical Trial of Multicenter, Randomized, Double-blind, Placebo Parallel Control

ClinicalTrials.gov record

Registration

Registration: NCT06649773
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 137
Start: 2024-11-06
Primary completion: 2025-05-28
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:Noiiglutide Injection; DRUG:Noiiglutide Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Changes in glycated hemoglobin (HbA1c) relative to baseline at week 24 in SHR20004 compared to placebo. [Week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.